Investor · Berkeley, CA
Rachel E. Haurwitz
Open Rachel in the network graph →Capital
$129.5M
across filings
Active
Dec 2015
to Mar 2021
Most-connected co-filers (59)
Robert Weisskoff · Berkeley, CA9 sharedAndrew Ervin · Boston, MA8 sharedAlberto S. Montoya · VANCOUVER, British Columbia, Canada8 sharedMarion A. Mcgrath · VANCOUVER, British Columbia, Canada8 sharedMats Lederhausen · Needham, MA8 sharedAlan C. Smith · Auburndale, MA6 sharedEstuardo Aguilar-Cordova · Auburndale, MA6 sharedKenneth Luginbuhl · Ellington, CT6 sharedFred C. Mermelstein · Auburndale, MA6 sharedRobert S. Wasylyshyn · VANCOUVER, British Columbia, Canada6 sharedMaria Milagros A. Paredes · VANCOUVER, British Columbia, Canada6 sharedUdi C. Merav · Auburndale, MA6 sharedGlenn C. Mattes · Auburndale, MA6 sharedMitchell C. Finer · Auburndale, MA6 sharedLaura Aguilar · Auburndale, MA6 sharedArlo Hoffman · Ellington, CT6 sharedCyrus Driver · Vancouver, British Columbia, Canada6 sharedMatthew A. Blanchard · San Diego, CA6 sharedStephen C. Rocamboli · Auburndale, MA6 sharedSeth Bahler · Ellington, CT6 sharedRick Metzger · Morris, MN6 sharedBarbara G. Mcclung · Berkeley, CA4 sharedNancy A. Zweng · VANCOUVER, British Columbia, Canada2 sharedWayne Willis · Sterling, VA2 shared Recent filings (12)
Caribou Biosciences, Inc.Mar 2021 · 18 co-filers$115.0MFormula XO, Inc.Oct 2016 · 14 co-filers$750KAdvantagene, Inc.Sep 2016 · 21 co-filers$35.0MAdvantagene, Inc.Jul 2016 · 21 co-filers$35.0MAdvantagene, Inc.Jun 2016 · 21 co-filers$35.0MCaribou Biosciences, Inc.May 2016 · 18 co-filers$30.1MAdvantagene, Inc.May 2016 · 21 co-filers$35.0MAdvantagene, Inc.Apr 2016 · 21 co-filers$35.0MAdvantagene, Inc.Dec 2015 · 21 co-filers$2.5MFormula XO, Inc.Dec 2015 · 14 co-filers$700KIntellia Therapeutics, Inc.Sep 2015 · 12 co-filers$70.0MIntellia Therapeutics, Inc.Sep 2015 · 12 co-filers$70.0MCaribou Biosciences, Inc.Mar 2015 · 12 co-filers$11.5M Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Rachel in the interactive graph →